Recurrent Lung Adenocarcinoma Complicated by a Tracheopericardial Fistula
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage II
- Subtype
- Adenocarcinoma
- Biomarkers
- No gene mutations identified on postoperative testing
- Sex
- male
- Treatment
- surgery, chemotherapy, radiation and targeted therapy
- Outcome
- In Memory
Treatment course, step by step
- Underwent right upper lobectomy in November 2016 followed by 6 cycles of postoperative chemotherapy.
- Received 3 cycles of cisplatin and pemetrexed when mediastinal recurrence was suspected in 2018, then declined further chemotherapy.
- In 2024, underwent bronchoscopic tumor-debulking procedures and radiation for airway involvement.
- Later received 3 cycles of pemetrexed, carboplatin and bevacizumab with a favorable response.
What happened, in summary
A 72-year-old man had undergone right upper lobectomy for Stage II lung adenocarcinoma in November 2016, followed by 6 cycles of chemotherapy. Tumor testing did not identify a gene mutation that could guide targeted treatment.
In October 2018, an enlarging mediastinal lymph node raised concern for recurrence. He received 3 cycles of cisplatin and pemetrexed, then declined further chemotherapy and continued follow-up. By early 2024, recurrent tumor was involving the trachea and causing severe airway narrowing. He underwent two bronchoscopic tumor-debulking procedures and radiation. When the disease progressed further, he received 3 cycles of pemetrexed, carboplatin and bevacizumab and responded favorably.
In June 2024, he was admitted with fever and chest pain. An initial heart-attack evaluation was negative. Imaging instead showed air around the heart, and bronchoscopy identified a fistula connecting the trachea with the pericardial space. Drainage and antibiotics were started while closure of the fistula was planned.
On the fifth hospital day, he developed massive hemoptysis followed by cardiac and respiratory arrest and could not be resuscitated. He died about 7½ years after his November 2016 lung-cancer diagnosis.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 2 Lung Cancer 25 stories
- Bevacizumab for Lung Cancer 37 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer